Cargando…

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

Detalles Bibliográficos
Autores principales:	Gray, GE, Bekker, L, Churchyard, G, Nchabeleng, M, Mlisana, K, de Bruyn, G, Roux, S, Mathebula, M, Latka, M, Bennie, T, Metch, B, Moodie, Z, Allen, M, Eaton, N, Kublin, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767703/ http://dx.doi.org/10.1186/1742-4690-6-S3-P209

Ejemplares similares

Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women
por: Latka, Mary H., et al.
Publicado: (2012)

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine
por: Latka, M, et al.
Publicado: (2009)

HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
por: Volk, JE, et al.
Publicado: (2012)

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
por: Allen, MA, et al.
Publicado: (2009)

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)

P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
por: de Bruyn, G, et al.
Publicado: (2009)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
por: Hopkins, Kathryn L., et al.
Publicado: (2014)

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men
por: Moodie, Zoe, et al.
Publicado: (2015)

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
por: Koblin, B, et al.
Publicado: (2012)

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial
por: Mpofu, Rephaim, et al.
Publicado: (2021)

Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa
por: Lazarus, Erica Maxine, et al.
Publicado: (2014)

P15-15. Advocates' perspectives on community engagement in the HVTN 505
por: Warren, M, et al.
Publicado: (2009)

Natural unblinding of BCG vaccination trials
por: Szigeti, Reka, et al.
Publicado: (2021)

Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
por: Hardy, John, et al.
Publicado: (2023)

Discovery medicine – the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine
por: Martin, Troy M., et al.
Publicado: (2023)

Blinded and unblinded sample size reestimation in crossover trials balanced for period
por: Grayling, Michael J., et al.
Publicado: (2018)

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
por: Churchyard, Gavin J., et al.
Publicado: (2011)

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)
por: Peiperl, Laurence, et al.
Publicado: (2010)

Home phototherapy for hyperbilirubinemia in term neonates—an unblinded multicentre randomized controlled trial
por: Pettersson, M., et al.
Publicado: (2021)

P06-08. Building an African HIV preventive trial network
por: Price, MA, et al.
Publicado: (2009)

Oral and oropharyngeal high-risk HPV prevalence, HIV status, and risk behaviours in a cohort of South African men who have sex with men
por: Mistry, Harshita B, et al.
Publicado: (2021)

Point-of-Care Diagnostic Device for Traumatic Pneumothorax: Low Sensitivity of the Unblinded PneumoScan™
por: Rehfeldt, M., et al.
Publicado: (2018)

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2018)

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
por: Fong, Youyi, et al.
Publicado: (2018)

The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023
por: Parker, Richard A.
Publicado: (2023)

503. Risk and Timing of Clostridium difficile Infection Relapse After Antibiotic Exposure
por: Szela, Joel, et al.
Publicado: (2018)

Poster Sessions 313-503
Publicado: (2004)

DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
por: Morgan, C, et al.
Publicado: (2012)

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial
por: Pantaleo, Giuseppe, et al.
Publicado: (2019)

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120
por: deCamp, Allan C., et al.
Publicado: (2017)

LncRNA ZNF503-AS1 promotes RPE differentiation by downregulating ZNF503 expression
por: Chen, Xue, et al.
Publicado: (2017)

Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials
por: Kunzmann, Kevin, et al.
Publicado: (2022)

Reducing inappropriate outpatient antibiotic prescribing: normative comparison using unblinded provider reports
por: Milani, Richard V, et al.
Publicado: (2019)

Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations
por: Kunz, Cornelia U., et al.
Publicado: (2016)

Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
por: Stoehr, Jenna Rose, et al.
Publicado: (2021)

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
por: Laher, Fatima, et al.
Publicado: (2020)

Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials)
por: Betz, Michael, et al.
Publicado: (2020)

Treatment of 503 cattle with traumatic reticuloperitonitis
por: Braun, Ueli, et al.
Publicado: (2018)

Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials
por: Liu, Junhao, et al.
Publicado: (2020)

Optics studies based on V6.503 nominal configuration
por: Aiba, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fbvf65d31svdbajfdvhqmr73tt